Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending April 2012. The report serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, specifically regarding the SmithKline Beecham Mid-Term Incentive Plan.
Key Financial Metrics
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure of a specific insider transaction rather than a financial performance report.
Material Changes
The filing discloses an increase in the American Depositary Shares (ADSs) held by Mr. E J Gray. This increase resulted from the re-investment of the dividend paid to shareholders on April 12, 2012, at a price of $45.47 per ADS. The transaction involved 25,660 ADSs.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It strictly adheres to the Disclosure and Transparency Rule 3.1.4R(1)(a) regarding the notification of the aforementioned transaction.
Key Facts for Investor Verification
- Transaction Date: April 18, 2012 (Notification date); April 12, 2012 (Dividend payment date).
- Individual Involved: Mr. E J Gray.
- Transaction Type: Increase in ADS holdings via dividend re-investment.
- Share Price: $45.47 per ADS.
- Volume: 25,660 ADSs.